CheckMyRecalls

ASEGUA THERAPEUTICS LLC recalls Sofosbuvir and Velpatasvir

Published
16 Apr 2025
Units affected
18,541 cartons.
Agency
FDA
Country
United States

The hazard

Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1

Brand / company
ASEGUA THERAPEUTICS LLC
Codes / lots
Lot# 24ASV002UA, Exp Date: 6/30/2028
Distribution
US Nationwide
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 16 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.